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Abstract
Background: Prescription writing is a process which transfers the therapeutic message from the prescriber to the
patient through the pharmacist. Prescribing errors, drug duplication and potential drug-drug interactions (pDDI)
in prescriptions lead to medication error. Assessment of the above was made in prescriptions dispensed at State
Pharmaceutical Corporation (SPC), Anuradhapura, Sri Lanka.
Methods: A cross sectional study was conducted. Drugs were classified according to the WHO anatomical,
therapeutic chemical classification system. A three point Likert scale, a checklist and Medscape online drug
interaction checker were used to assess legibility, completeness and pDDIs respectively.
Results: Thousand prescriptions were collected. Majority were hand written (99.8 %) and from the private sector
(73 %). The most frequently prescribed substance and subgroup were atorvastatin (4 %, n = 3668) and proton pump
inhibitors (7 %, n = 3668) respectively. Out of the substances prescribed from the government and private sectors,
59 and 50 % respectively were available in the national list of essential medicines, Sri Lanka. Patients address (5 %),
Sri Lanka Medical Council (SLMC) registration number (35 %), route (7 %), generic name (16 %), treatment symbol
(48 %), diagnosis (41 %) and refill information (6 %) were seen in less than half of the prescriptions. Most were
legible with effort (65 %) and illegibility was seen in 9 %. There was significant difference in omission and/or errors
of generic name (P = 0.000), dose (P = 0.000), SLMC registration number (P = 0.000), and in evidence of pDDI (P = 0.
009) with regards to the sector of prescribing. The commonest subgroup involved in duplication was non-steroidal
anti-inflammatory drugs (NSAIDs) (43 %; 56/130). There were 1376 potential drug interactions (466/887
prescriptions). Most common pair causing pDDI was aspirin with losartan (4 %, n = 1376).
Conclusion: Atorvastatin was the most frequently prescribed substance. Fifteen percent of the prescriptions
originate from government sector. SLMC registration number and trade names were seen more in prescriptions
originating from the private sector. Most prescriptions were legible with effort. NSAIDs were the commonest
implicated in drug class duplication. Fifty three percent of prescriptions have pDDI.
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Background
Prescription writing is a science, art and a basic skill that
every prescriber needs to learn. It transfers the thera-
peutic message from the prescriber to the patient
through the pharmacist [1]. An error in a prescription
may introduce adverse effects and potential drug - drug
interaction (pDDI). Drug related complications were
found to be common in hospital based studies [2]. Guid-
ance on prescribing is provided in the British National
Formulary (BNF) and in a practical manual published by
World Health Organization (WHO) [3, 4].
Knowledge on drug utilization in a particular popula-
tion can be used to improve the supply of drugs to that
particular population. The present drug dispensing sys-
tem in Sri Lanka makes it difficult to assess drug
utilization. Reasons are poor record keeping, lack of
coordination between government and private sector and
drug dispensing without, expired or incorrect prescriptions.
The prescribing error is defined as follows
“A clinically meaningful prescribing error occurs
when, as a result of a prescribing decision or prescrip-
tion writing process, there is an unintentional but
significant
i. Reduction in the probability of treatment being
timely and effective or
ii. Increase in the risk of harm when compared with
generally accepted practice” [5].
Legibility of prescriptions is a legal duty of the pre-
scriber. The traditional prescription writing by hand in-
herits high incidence of documentation errors [6]. There
are instance where the prescriber has been found guilty
for the death of a patient as a result of illegible prescrip-
tion [7]. Previous studies have revealed the prevalence of
prescribing errors in prescriptions [8].
Drug interactions lead to toxicity or therapeutic failure
[9]. Resources to check pDDIs include formularies,
interaction tables, prescribing & dispensing software and
drug information services (e.g.,; Stockley’s Drug Interac-
tions, Medscape, Micromedex) [9].
The Sri Lankan health system includes allopathic,
ayurvedic and Sinhala medicine. Allopathic system con-
sist a universal free government sector and the fee levy-
ing private sector. Though Sri Lanka’s total expenditure
on health is 3.2 % of gross domestic product (GDP) for
the year 2013 its health indicators are comparable with
many of the more developed countries in Asia [10, 11].
Anuradhapura is the largest district in Northcentral
province and in Sri Lanka, with a population of nearly
856,500 by 2012 [12]. Majority of its population (94.6 %)
belong to the rural sector [12] and agriculture (55 %) is
their main employment (unemployment rate is 3.1 %)
[13]. The mean monthly household income of
Anuradhapura is Sri Lankan rupees 35,460, which is low
compared to the overall mean monthly household in-
come of the country (Sri Lankan rupees 45,878) [14].
The only tertiary care hospital available for the entire
district is situated in Anuradhapura town, the teaching
hospital Anuradhapura which is owned by the govern-
ment. This makes it the only choice for patients of
Anuradhapura to seek specialized care such as cardiology,
intensive care, nephrology etc. The SPC of Sri Lanka is an
institute that procures, produces and distributes pharma-
ceuticals with retail outlets Island wide. It was established
in 1971 as a result of the work by Prof. Senaka Bibile and
Dr. S.A. Wickramasinghe [15]. It promotes generic pre-
scribing and sells drugs in a much affordable price com-
pared to private pharmacies in the country. The only
outlet of SPC in Anuradhapura is situated very closer to
the teaching hospital Anuradhapura. The next outlet of
SPC is either in Polonnaruwa, Kurunegala or Jaffna dis-
tricts which are 100, 115 and 200 km away respectively
[15]. Therefore large number of low income and rural
population visits aforementioned SPC to obtain drugs.
In Sri Lankan health system, there are no regulations
in practice to monitor drug prescription and to define
the maximum number of drugs per prescription. This is
a leeway for higher number of prescription errors and
pDDIs per prescription.
Although there are few data from urban areas of Sri
Lanka, studies on drug utilization and prescription er-
rors of rural Sri Lanka are scarce. Knowledge on these
would help identify and address issues related specific-
ally to rural Sri Lanka. Our main objective was to assess
prescriptions dispensed in rural region for drug
utilization, prescription errors and pDDIs. The pDDI are
due to errors in prescribing. pDDIs and prescription
errors will indirectly dependent on patterns of drug
utilization. Findings of the patterns of drug utilization,
prescription errors and pDDIs are interrelated and
cannot be segregated. This would help to address them
subsequently. We chose State Pharmaceutical Corpor-
ation (SPC), Anuradhapura, Sri Lanka as our sample
population.
Methods
A descriptive cross sectional study was conducted at
SPC, Anuradhapura, Sri Lanka from May to August
2015. Every third prescription received at the SPC
Anuradhapura was selected. The WHO anatomical,
therapeutic chemical (ATC) classification system was
used to group the chemical substance. At the 1st level
the drugs are divided into 14 groups based on the ana-
tomical system they act on. Second level includes thera-
peutic subgroups. The 3rd and 4th levels are usually
pharmacological and chemical subgroups. The 5th level
is the chemical substance. The classification system uses
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International non-proprietary names. If this name is not
assigned to a particular drug then the system uses
United States adopted name or British approved name
[16]. All the chemical substances were checked for in-
clusiveness in the national list of essential medicines in
Sri Lanka [17].
The 3 points of the likert scale used to assess legi-
bility (the quality of being clear enough to read) were
as follows: 1 - Illegible, 2 - Legible with effort and 3
- Legible. The checklist (Additional file 1) used to as-
sess completeness included components of the pre-
scription mentioned both in the BNF and WHO
practical manual [3, 4]. Completeness was defined for
each component according to the above two resource
materials. The components were:
 Patient information (name, age, gender and address)
 Prescriber information (name, signature, Sri Lanka
Medical Council (SLMC) registration number below
prescribers’ signature, place of prescribing, contact
details, qualifications and prescriber's rubber stamp)
 Drug information {route of administration, generic
name, dose, frequency, duration and information for
the package label (the information written by the
prescriber and copied by the pharmacist onto the
label of the package. This includes the amount of
drug to be taken, frequency, any specific instructions
and warnings [4])}
 Other information (date & treatment symbol).
In addition, diagnosis of the disease and refill informa-
tion was included [18–20]. Data was anonymized so
identity of the patients or the prescribers was not col-
lected. Both the assessment of legibility and filling of the
checklist were done by trained Bachelor of Medicine,
Bachelor of Surgery (MBBS) qualified doctors. MBBS is
the first professional degree awarded, in medicine and
surgery upon graduation from medical school, by univer-
sities in countries that follow the common wealth trad-
ition. The tools were pre-tested for accuracy before the
data collection proper.
Drug duplication was defined as duplication of same
chemical substance in a single prescription. Drug class
duplication was defined as duplication of same chemical
sub-group in a single prescription.
The pDDIs were defined as each pair of drugs
known for possible interactions. When a single drug
combination caused pDDIs through more than one
mechanism, the mechanism of the most severe pDDIs
was considered. Medscape drug interaction checker
was used to identify pDDIs. It is an open access in-
formation service which verifies interactions between
brand and generic drugs, over-the-counter drugs and
supplements [21]. Up to 30 drugs, herbals, and
supplements can be checked at a time. The software
is available online, as a mobile application and the
results can be printed. There are three types of inter-
actions, serious, significant and minor. The pDDIs
were further categorized according to their mechan-
ism of action; pharmacodynamics (synergism or
antagonism), pharmacokinetics (absorption, distribution,
metabolism or elimination), other (mechanism known but
other than pharmacokinetics & pharmacodynamics, eg -
alterations in serum electrolytes, alterations in sedation
etc.) and unknown [21]. The data was analyzed using
Microsoft Excel and SPSS version - 21. Descriptive statis-
tics and chi square test were used to describe data. Mini-
mum sample size was calculated as 384 prescriptions
using the following formula [22]:
SS ¼ Z2x Pð Þ x 1−Pð Þ=d2
SS =Sample size for infinite population (where the popu-
lation is greater than 50,000)
Z = Z statistic for a level of confidence. For the level
of confidence of 95 %, which is conventional, Z
value is 1.96.
P = Expected prevalence or proportion
d = precision
The parameters used for calculating sample size were
95 % confidence level, an expected prevalence of 50 %
and 5 % absolute precision.
Results
Thousand prescriptions containing, 340 drugs (fifth
level chemical substances) with a frequency of 3668
times from 198 classes (fourth level chemical sub-
groups) were collected in four calendar months. All
most all were hand written (99.8 %). Most prescrip-
tions were from the private sector (73 %; 725/1000)
and 15 % were from the government sector. Out of
the total prescriptions 2.4 % were from a hospital
ward, 12.5 % from an outpatient department, 27.7 %
from a clinic and remaining were unclassified. Mean
number of drugs per prescription was 3.95 (SD 2.2).
The median and mode were 4.0 and 4.0 respectively.
It had a positively skewed distribution.
Most frequently prescribed substances
Atorvastatin, which is freely available in the universal
free government health care system, was the most fre-
quently prescribed drug (chemical substance) in both
the government and the private and unclassified sector
(Table 1). The most frequently prescribed chemical,
pharmacological and therapeutic sub-groups are shown
in Table 2. Twenty four different combination products
were found and among them (n = 229) multivitamins
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(24 %), iron with folic acid (17 %) and calcium with vita-
min D (14 %) were the most frequently prescribed
(Table 3). From the chemical substances prescribed from
the government sector 59 % (306/519) are available in
the national list of essential medicines, Sri Lanka and in
the private sector the figure is 50 % (1583/3149) [17].
Completeness and legibility of prescriptions
Table 4 shows assessment of completeness of the pre-
scriptions dispensed at SPC, Anuradhapura.
Address of the patient, SLMC registration number,
route of administration, generic name, treatment symbol,
diagnosis and refill information were seen in less than half
of the prescriptions. Information for the package label was
not seen in any of the prescriptions. Out of the prescrip-
tions which had prescriber's rubber stamp, only 39 %
(343/892) had the SLMC registration number. Omissions
and/or errors in generic name, dose and SLMC registra-
tion number were respectively 89 %, 72 %, 62 % (n = 845)
in the private sector and were significantly different when
compared to 67 %, 54 %, 82 % (n = 155) in the government
sector (Table 5). Most of the prescriptions were legible
with effort (65 %). Legible and illegible prescriptions were
26 and 9 % respectively.
Drug duplication
Drug duplication was found in three prescriptions with
omeprazole, etoricoxib and cetirizine. Drug class (chem-
ical sub-group) duplication was found in 130 out of 887
prescriptions, which had two or more drugs, involving
19 classes. The commonest was non-steroidal anti-
inflammatory drugs (NSAIDs) (43 %; 56/130). Chemical
subgroup duplication doesn’t have a significant differ-
ence with regards to the sector (Table 5).
Potential drug - drug interactions
Out of 887 prescriptions, which had two or more drugs,
466 (52.5 %) prescriptions had 1376 pDDI with a mean
of 1.6 (SD 2.5) per prescription. It was a positively
skewed distribution with median and mode being one
and zero respectively. Out of them 94 (7 %) were ser-
ious, 1017 (74 %) significant and 265 (19 %) minor
pDDIs. Table 6 shows the commonest pDDIs catego-
rized according to the severity. In a single prescription
the maximum numbers of serious, significant and minor
pDDIs were 05, 15 and 04 respectively. The highest
number of pDDI in a single prescription was 21 (this
prescription had 14 drugs in it). Hundred and seventy
eight different drugs were involved in pDDIs. The com-
monest pDDI was aspirin-losartan (4 %, n = 1376).
Table 1 Top 10 drugs in prescriptions dispensed at SPC Anuradhapura 2015
Total Government Private & Unclassified
Drug % (n = 3668) Drug % (n = 519) Drug % (n = 3149)
Atorvastatin 4.0 Atorvastatin 7.1 Atorvastatin 3.5
Losartan 3.8 Losartan 7.1 Metformin 3.5
Metformin 3.6 Aspirin 6.5 Losartan 3.3
Pantoprazole 2.9 Metformin 4.2 Pantoprazole 2.9
Aspirin 2.7 Clopidogrel 3.3 Gliclazide 2.5
Gliclazide 2.5 Pantoprazole 2.9 Aspirin 2.1
Diclofenac sodium 1.8 Gliclazide 2.7 Diclofenac sodium 1.9
Celecoxib 1.6 Amlodipine 2.5 Celecoxib 1.7
Clopidogrel 1.6 Domperidone 2.5 Esomeprazole 1.6
Omeprazole 1.6 Omeprazole 2.1 Prednisolone 1.6
Table 2 Top 5 subgroups (n = 3668) in prescriptions dispensed at SPC Anuradhapura 2015
ATC 4th level Percent ATC 3rd level Percent ATC 2nd level Percent
Chemical subgroup Pharmacological subgroup Therapeutic subgroup
Proton pump inhibitor 7.0 Anti-inflammatory and anti-rheumatic
products, non-steroids
8.8 Anti-inflammatory and anti-rheumatic
products
8.8
HMG CoA reductase inhibitors 5.0 Blood glucose lowering drugs, excluding
Insulins
8.3 Drugs used in diabetes 8.4
Angiotensin II antagonists, plain 4.9 Drugs for peptic ulcer and gastro-
oesophageal reflux disease (GORD)
7.6 Drugs for acid related disorders 7.9
Platelet aggregation inhibitors
excluding heparin
4.3 Lipid modifying agents, plain 5.8 Anti-bacterials for systemic use 7.3
Sulfonylureas 3.6 Angiotensin II antagonists, plain 4.9 Lipid modifying agents 5.8
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Pharmacokinetics was the commonest mechanism in-
volved in serious (40.4 %, n = 94) and minor (50.6 %, n =
265) pDDIs. Commonest mechanism involved in signifi-
cant pDDI was ‘other’ (29.4 %, n = 1017). Additional file
2 shows commonest pDDIs for different mechanisms.
pDDIs was low in the prescriptions originating from pri-
vate sector (51 %; 384/758) compared to the government
sector (64 %; 82/129) (Table 5).
Discussion
Statins and combination of aspirin-losartan was the
most frequently prescribed and commonest pDDI re-
spectively. Patient address, SLMC registration number,
route, generic name, treatment symbol, diagnosis and re-
fill information were absent in more than half of the pre-
scriptions. Most prescriptions were legible with effort.
Almost all prescriptions were handwritten. There were
no prescriptions produced by electronic prescribing sys-
tem. This may be because of lack of equipment, funding,
overcrowding or lack of computer literacy. Concerns on
consumer security, privacy and confidentiality would
have contributed [23]. Previous studies have shown that
the electronic prescribing system leads to reduction of
prescription errors [18, 24].
There were 155 prescriptions from the government sec-
tor. Unavailability of the drugs, long queues at the govern-
ment drug dispensing counters and patient preference
may have led to the above finding. Out of the drugs pre-
scribed from the government and private sectors, 59 %
and 50 % respectively were from the national list of essen-
tial medicines [17]. A study conducted in Galle, Sri Lanka
during the year 2002 had found 39.6 % (322/812) of the
drugs prescribed in the private sector were from this na-
tional list [25]. This list of essential medicines was updated
in 2014 and may have resulted in the change. The overall,
rural and urban percentages of drugs prescribed from the
essential drug list of a study in India were 37, 35 and 40
respectively [26]. Unclassified group of prescriptions with
regards to sector may be due to prescriber’s negligence or
non-institutional prescribing.
Average number of drugs per prescription was 3.95
with a median of four. In a previous study this number
was six (median) among elderly patients in Sri Lanka
[27]. In a study of 10 developing countries the average
number of drugs per prescription was between 1.3 and
2.2 for general outpatient encounters [28]. This shows
that number of drugs per prescription is high in Anura-
dhapura. Average number of drugs per prescription in
rural and urban areas were 4 and 5 respectively in an
Indian study [26]. Top three combination products
(67 %; 154/229) dispensed are vitamins and minerals.
Lack of knowledge on rational prescribing, differences in
guidelines and placebo prescribing may be the reasons.
Table 4 Completeness of prescriptions (Total = 1000) dispensed
at SPC Anuradhapura 2015
Component of the prescription Present (complete/
correct)
Patient information
1. Name of patient 94 (42c)
2. Age of patient 79
3. Gender of patient 70
4. Address of patient 5
Prescriber information
5. Name of prescriber 90 (98c)
6. Signature of prescriber 84
7. SLMC registration number 35
8. Place of prescribing 76
9. Contact details of prescriber 53
10. Qualifications of the prescriber 86
11. Prescriber's rubber stamp containing - Full
name, qualifications, and registration
number below his signature
89 (36c)
Drug information
12. Route of administration 7 (90b)
13. Generic name of drug 16 (87b)
14. Dose of drug 93 (33b)
15. Frequency of drug 97 (68b)
16. Duration of drug 92 (84b)
Other information
17. Treatment symbol 48 (61b)
18. Date of prescribing 88 (94c)
19. Diagnosis of the diseasea 41
20. Refill informationa 6
aItem 19 & 20 are in addition to the guidelines available in the BNF and WHO
manual [3, 4]
bCorrect, cComplete
Table 3 Combination products prescribed in prescriptions
dispensed at SPC Anuradhapura 2015
No Groups of combined preparations % (n = 229)
01 Vitamins 36
02 Anti-anemic preparations 17
03 Mineral supplements 14
04 Drugs for obstructive airway diseases 11
05 Analgesics 09
06 Corticosteroids, dermatological preparations 04
07 Anti-acne preparations 04
08 Drugs for acid related disorders 02
09 Vasoprotectives 01
10 Antifungals for dermatological use 01
11 Anti-Parkinson drugs 01
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The US review showed antihypertensive and levothyr-
oxine as the top chemical sub-group and chemical sub-
stance by prescriptions respectively [29]. The UK Report
found amoxicillin as the top chemical substance pre-
scribed [30]. Our study found overall proton pump in-
hibitors and atorvastatin as the top chemical sub-group
and chemical substance by prescriptions respectively.
They are also available in the government pharmacies.
Antibiotics were the top chemical sub-group prescribed
in a study conducted in rural India [26]. Differences in
disease patterns and prescribing patterns would have
contributed for the above finding.
SLMC registration number is given to all qualified
doctors who practice and prescribe in Sri Lanka [31].
Using the SLMC registration number indirectly helps to
stop quacks practicing medicine by identifying legitimate
allopathic practioners. Only 35 % of the prescriptions
had the number. Even among the prescriptions (n = 890)
that had prescriber’s rubber stamp only 39 % had the
SLMC registration number. Absence of SLMC registra-
tion number was more common in prescriptions origin-
ating from government sector. A previous study in
Kandy, Sri Lanka found SLMC registration number only
in 16 % (n = 200) [32]. Prescribers from private sector
may be more concerned about their right to prescribe
and to identify themselves as western medical practi-
tioners, hence increased use of SLMC registration num-
ber that identifies themselves as prescribers with
provenance to practice allopathic medicine.
Generic name was present only in 11 % of the private
sector prescriptions which was lesser than in the study
conducted in 2002 at the private sector of Galle, Sri
Lanka (36.7 %) [25]. The drugs prescribed by generic
name were 52 and 71 % respectively in rural and urban
India [26].
Only 48 % of the prescriptions had the treatment
symbol. The treatment symbol is derived from Recipe
(Latin for ‘take’) and gives a legal validity to prescrip-
tions. After the symbol the prescriber should write the
name and strength of the drug [4].
Name, age, gender and diagnosis were missing in
more prescriptions (6 %, 21 %, 30 %, 59 %) of rural
Sri Lanka compared to rural India (0 %, 0 %, 0 %,
28 %). The prescribers signature was present in more
prescriptions of rural Sri Lanka (84 %) compared to
rural India (45 %).
The WHO manual and the BNF [3, 4] has not in-
cluded diagnosis and refill information however it may
be important for following reasons. One drug can be
prescribed for two different reasons (Eg-Propanolol in
hypertension and migraine). Mentioning of diagnosis
reduces confusion among the drug dispensers. Refill
information (Eg - Do not repeat/Repeat once) will help
curtail drug abuse and misuse. Diagnosis (41 %) and
refill information (6 %) were seen in less than half of the
prescriptions.
According to the WHO manual it is the legal duty of
the doctor to write legibly [4]. In our study 26 % of the
prescriptions are legible and 9 % are illegible. In Galle
26 % (n = 812) [25] and in Kandy 50 % (n = 200) [32]
were illegible. However methods used to assess legibility
in Kandy is not clear as it is an abstract. Legibility
was 23 and 59 % in rural and urban areas of India
respectively [26]. However the method used to assess
legibility was not clear. Compared to a study done in
Saudi Arabia (1 %) [33], drug duplication was lower
in our study (0.3 %).
Consideration of pDDIs in a prescription not only
helps to avoid or minimize them it also assists in moni-
toring and warning the patient on pDDIs. Comparison
of the findings of pDDIs was made with the study done
in Ahmedabad, India in 2014 [34] again using the Meds-
cape drug interaction checker (Additional file 2). The
comparison shows similarity in distribution of severity of
pDDIs and commonest pharmacodynamic pDDI (as-
pirin-losartan). Percentage of prescriptions having
pDDIs and mean pDDI per prescription was low in our
study (53 % &1.6) compared to the Indian (83 % & 5.9).
Maximum number of pDDI per prescription was 21 in
our study compared to 33 in the Indian. The commonest
pDDI was aspirin-losartan in our study and metoprolol-
aspirin in the Indian [34]. The reasons for the dissimilar-
ity may be due to the differences in the disease and
prescribing pattern.
Table 5 Errors in prescriptions dispensed at SPC Anuradhapura 2015
Route Generic name Dose Frequency Duration pDDIs Drug class Duplication SLMC Number
(n = 1000) (n = 1000) (n = 1000) (n = 1000) (n = 1000) (n = 887) (n = 887) (n = 1000)
C I C I C I C I C I P A P A C I
Government 11 144 52 103 71 84 105 50 120 35 82 47 25 104 28 127
Private &
Unclassified
52 793 93 752 233 612 558 287 649 196 384 374 105 653 320 525
X2 (df = 1) 0.070 51.883 19.73 0.103 0.004 6.856 2.269 21.778
P-value 0.792 0.000 0.000 0.748 0.950 0.009 0.132 0.000
C – Present, Correct or Complete; I – absent, Incorrect or Incomplete, P - Present; A - Absent
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Though we used the open access Medscape drug
interaction checker there are formulas and commer-
cially available drug information systems [9]. The
commonest combination causing pDDIs was aspirin-
losartan but a study done using the Micromedex
system in a cardiac clinic at south-west Ethiopia
found enalapril-frusemide as the commonest [35].
The reason may again be the differences in the epi-
demiology of disease and prescribing pattern. pDDIs
have a significant difference with regards to the sector
(p = 0.009). pDDIs was low in the prescriptions origin-
ating from private sector compared to the govern-
ment sector. Reasons may be lack of resource to
check for pDDI, lack of time to check for pDDI due
to overcrowding and lack of concern.
The study had limitations such as being confined to
SPC, Anuradhapura, unavailability of a standard pre-
scription format in Sri Lanka and the pDDIs being
assessed using only open access software. Yet the
present study was capable in producing valuable findings
which could provide a basic platform for future studies.
Conclusion
Fifteen percent of the prescriptions originate from gov-
ernment sector. Reasons that drive consumers away
from the government drug dispensing services (where
products and services are free) are not clear. SLMC
registration number and trade names were seen more in
prescriptions originating from the private sector. Find-
ings on legibility, completeness, drug duplication and
pDDIs show that there is room for improvement in pre-
scriptions originating from rural Sri Lanka. Island wide
studies (to find out generalized data), root cause analysis
(on prescription errors) and formation of a validated
prescription template (in view of regulating prescription
writing) are recommended.
Additional files
Additional file 1: Assessment of legibility and completeness of
prescriptions received at State Pharmaceutical Corporation,
Anuradhapura-Check List. (DOC 53 kb)
Additional file 2: Comparison of findings on pDDIs found by Medscape
drug interaction checker. (DOC 39 kb)
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ATC, anatomical therapeutic and chemical; BNF, British National Formulary;
GDP, gross domestic product; pDDI, potential drug-drug interaction; MBBS,
Bachelor of Medicine, Bachelor of Surgery; NSAIDs, non steroidal anti
inflammatory drugs; SD, standard deviation; SLMC, Sri Lanka Medical Council;
SPC, State Pharmaceutical Corporation; SPSS, statistical package for the social
science; UK, United Kingdom; US, United States; WHO, World Health
Organization
Table 6 Common pDDIs of prescriptions dispensed at SPC
Anuradhapura 2015
Combination (%) Mechanism of pDDI according to the
Medscape drug interaction checker [21]
Serious (Total = 94)
Methotrexate-Leflunomide (6.4) Leflunomide increases toxicity of
methotrexate by pharmacodynamic
synergism.
Meloxicam-Methotrexate (5.3) Meloxicam increases levels of
methotrexate by decreasing renal
clearance.
Clopidogrel-Omeprazole (5.3) Omeprazole decreases effects of
clopidogrel by affecting hepatic
enzyme CYP2C19 metabolism.
Clopidogrel-Esomeprazole (5.3) Esomeprazole decreases effects of
clopidogrel by affecting hepatic
enzyme CYP2C19 metabolism.
Atorvastatin-Vitamin B3 (5.3) Either increases toxicity of the other
by pharmacodynamic synergism.
Atorvastatin-Fenofibrate (5.3) Either increases effects of the other
by pharmacodynamic synergism.
Significant (Total = 1017)
Aspirin-Losartan (5.5) Aspirin decreases effects of losartan
by pharmacodynamic antagonism.
losartan and aspirin both increase
serum potassium.
Losartan-Frusemide (3.2) Losartan increases and furosemide
decreases serum potassium.
Aspirin-Clopidogrel (3.0) Either increases toxicity of the other
by pharmacodynamic synergism.
Clopidogrel-Pantoprazole (2.3) Pantoprazole decreases effects of
clopidogrel by affecting hepatic
enzyme CYP2C19 metabolism.
Celecoxib-Diclofenac sodium (2.0) Celecoxib and diclofenac both increase
anticoagulation and serum potassium.
Aspirin-Frusemide (2.0) Aspirin increases and furosemide
decreases serum potassium.
Minor (Total = 265)
Glipizide - Sitagliptin (7.6) Either increases effects of the other
by pharmacodynamic synergism.
Metformin - Vitamin B12 (5.7) Metformin decreases levels of
cyanocobalamin by unspecified
interaction mechanism.
Metformin-Frusemide (3.8) Metformin decreases levels of
furosemide by unspecified
interaction mechanism. Furosemide
increases levels of metformin by
unspecified interaction mechanism.
Methotrexate - Folic acid (3.4) Folic acid decreases effects of methotrexate
by pharmacodynamic antagonism.




Hydrochlorothiazide will increase the
level or effect of metformin by basic
(cationic) drug competition for renal
tubular clearance. Hydrochlorothiazide
decreases effects of metformin by
pharmacodynamic antagonism.
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